# The Decoder — OpenAI acquires Orchestra Bio to build AI agents that speed up drug development

- Company: The Decoder (the-decoder.com)
- Announced: 2026-10-21T08:32:54+00:00
- Category: partnership-acquisition
- Coverage: not counted
- Announcement: yes
- Group: announcements
- Source: https://the-decoder.com/openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development/
- Record: https://forck.live/items/25737-openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development
- Subject: Reporting

OpenAI has acquired Orchestra Bio, a startup that helps pharma teams coordinate drug development, and will fold it into Rosalind, its AI platform for life sciences. The combined effort is meant to build AI agents that link scientific findings with clinical trials, decisions and next steps so new drugs reach patients faster. Developing a drug in the US takes ten to 15 years on average, and siloed systems plus constant back-and-forth between internal teams and outside partners slow things down. Orchestra's agents track trials, flag affected timelines when something goes wrong such as a failed production batch, and surface options for what to do next, which could free scientists to focus on decisions and the actual research. Rosalind includes GPT-Rosalind, which helps researchers analyze biological and chemical questions, and Rosalind Workbench, which connects those capabilities with scientific data and tools. OpenAI already works with Novo Nordisk and Moderna on AI-driven pharma research, and financial terms of the deal weren't disclosed.

## Evidence

Verbatim from https://the-decoder.com/openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development/:

> Orchestra's agents are designed to take work off teams' plates by tracking trials, flagging affected timelines when something goes wrong like a failed production batch, and surfacing options for what to do next. That could free scientists to focus on decisions and the actual research.

---

Record: https://forck.live/items/25737-openai-acquires-orchestra-bio-to-build-ai-agents-that-speed-up-drug-development
Catalogue: https://forck.live/llms.txt
Current issue: https://forck.live/feed.md